Leber Steven E

Avg. Two Year Performance

15% Avg. Purchase Return
7% Compound
No sale track record
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return(15%)(11%)(44%)(43%)15%
Purchase Success Rate0 of 20 of 20 of 20 of 21 of 2
Average Sale Return----------
Sale Success Rate----------
Drugs » Biotechnology

Chairman/CEO, Director, 10% Owner:

Holdings: 14.97M shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--